EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Nymox Pharmaceutical Corporation
August 10 2016 - 12:36PM
Business Wire
Rosen Law Firm, a global investor rights law firm, announces it
is investigating potential securities claims on behalf of
shareholders of Nymox Pharmaceutical Corporation (NASDAQ: NYMX)
resulting from allegations that Nymox may have issued materially
misleading business information to the investing public.
On August 10, 2016, Seeking Alpha published an article revealing
that Nymox management has consistently and repeatedly misled
shareholders about its prospects in a material way while
dumping stock at inflated prices without making timely disclosures
to the Securities and Exchange Commission. On this news, shares of
Nymox fell sharply during intraday trading on August 10, 2016.
Rosen Law Firm is preparing a class action lawsuit to recover
losses suffered by Nymox investors. If you purchased shares of
Nymox on or before August 10, 2016, please visit the firm’s website
at http://www.rosenlegal.com/cases-933.html for more information.
You may also contact Phillip Kim or Kevin Chan of Rosen Law Firm
toll free at 866-767-3653 or via email at pkim@rosenlegal.com or
kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout the globe,
concentrating its practice in securities class actions and
shareholder derivative litigation.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160810005872/en/
The Rosen Law Firm, P.A.Laurence Rosen, Esq.Phillip Kim,
Esq.Kevin Chan, Esq.275 Madison Avenue, 34th FloorNew York, NY
10016Tel: 212-686-1060Toll Free: 866-767-3653Fax:
212-202-3827lrosen@rosenlegal.compkim@rosenlegal.comkchan@rosenlegal.comwww.rosenlegal.com
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nymox Pharmaceutical (NASDAQ:NYMX)
Historical Stock Chart
From Apr 2023 to Apr 2024